Funded Tech Companies
Medherant
Wondering who backed Medherant? Mercia Fund Management joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Medherant
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
The Venture Centre University of Warwick Science Park Sir Wi
Coventry, CV4 7EZ
UK
Coventry, CV4 7EZ
UK
Phone
Website
Email Address
Company Background Information
Overview
Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch®. The company's lead project is a testosterone patch for women. There is considerable interest in the transdermal delivery of drugs to overcome some of the disadvantages of oral administration, such as spikes in drug levels that can lead to side effects, and poor compliance. Patches are also a more convenient way to deliver drugs through the skin than gels and creams and provide better dose control.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/4/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Burt
Chief Financial Officer
James Robson
Co-Founder
David Haddleton
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs